Global Vaccines Market with focus on China: Industry Analysis & Outlook (2018-2022)

Publisher Name :
Date: 06-Aug-2018
No. of pages: 85
Inquire Before Buying

The immune system is considered as the body’s natural defense against germs. When a germ enters the body, the immune system sends special cells to fight it off. The immune system is not naturally strong enough to prevent a disease from seriously harming a person. But there’s a way to give the immune system a boost, it is known as vaccine. A vaccine is a biological preparation that provides active acquired immunity to a specific disease. A vaccine naturally contains an agent that resembles a disease causing microorganism and is often made from weakened or killed forms of the microbe, its surface proteins or toxins. The administration of vaccines is called vaccination. Vaccination is the most effective method of preventing infectious diseases. Widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and restriction of diseases such as polio, measles and tetanus.

The U.S. is a major contributor to the global vaccines market supported by increasing disposable income of the population and mass awareness of newly developed vaccines in the region. Also, research and development efforts to develop new vaccines to prevent the population from infections and diseases fueled the growth of vaccines market.

The global vaccines market is expected to grow in future due to increasing disposable income, rising healthcare expenditure, increasing demand for HPV vaccines and rapid urbanization. Key trends of this market include global uptake of routine immunization, emergence of new and innovative vaccines and increase in global vaccines expenditure per capita by country. However, there are some factors which can hinder the market growth including stringent legal norms, risks associated with manufacturing and transportation and slow progress of research and development.

The report “Global Vaccines Market with Focus on China: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., India and China. The report profiles the key players of the market including Merck & company, Sanofi, Pfizer and GlaxoSmithKline.

Global Vaccines Market with focus on China: Industry Analysis & Outlook (2018-2022)

Table of Contents

1. Overview
1.1 Vaccine
1.2 Types of Vaccines
1.3 Vaccine Industry

2. Global Vaccines Market
2.1 Global Vaccines Market by Value
2.2 Global Vaccines Market Forecast by Value
2.3 Global Vaccines Market by Diseases
2.4 Global Vaccines Market by Product
2.4.1 Global Tail Products by Value
2.4.2 Global Tail Products Forecast by Value
2.4.3 Global New and Pipeline Products by Value
2.5 Global Vaccines Market Value by Country Type
2.6 Global Vaccines Market Volume by Country Type
2.7 Global Vaccines Market by Region

3. Regional Vaccines Market
3.1 The U.S.
3.1.1 The U.S. Vaccines Market by Value
3.1.2 The U.S. Vaccines Market Forecast by Value
3.2 India
3.2.1 India Vaccines Market by Volume
3.2.2 India Private Vaccines Market by Value
3.2.3 India Private Vaccines Market Forecast by Value
3.2.4 India Private Vaccines Market by Vaccine Type

4. China Vaccines Market
4.1 China Vaccines Market by Value
4.2 China Vaccines Market Forecast by Value
4.3 China Vaccines Market by Type
4.3.1 China Type 1 Vaccines Market by Value
4.3.2 China Type 1 Vaccines Market Forecast by Value
4.3.3 China Type 2 Vaccines Market by Value
4.3.4 China Type 2 Vaccines Market Forecast by Value
4.4 China Type 2 Vaccine Product Market
4.4.1 China HPV Vaccines Sales Volume Forecast
4.4.2 China HPV 4 Vaccines Sales Forecast by Value
4.4.3 China HPV 9 Vaccines Sales Forecast by Value
4.4.4 China Selected Vaccines Penetration

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Disposable Income
5.1.2 Rising Healthcare Expenditure
5.1.3 Increasing Demand for HPV Vaccines
5.1.4 Rapid Urbanization
5.2 Key Trends
5.2.1 Global Uptake of Routine Immunization
5.2.2 Emergence of New and Innovative Vaccines
5.2.3 Global Vaccines Expenditure Per Capita by Country
5.3 Challenges
5.3.1 Slow Progress in Research and Development Activities
5.3.2 Stringent Legal Norms
5.3.3 Risks Associated with Manufacturing and Transportation

6. Competitive Landscape
6.1 Global Market
6.1.1 Global Vaccines Market Share by Company
6.1.2 Revenue and Market Cap Comparison
6.2 Indian Market
6.2.1 India Private Vaccines Market Share by Company

7. Company Profiles
7.1 Merck & Company
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Pfizer
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Sanofi
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 GlaxoSmithKline (GSK)
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies

List of Tables

Generation and Types of Vaccines
Key Players - Revenue & Market Cap Comparison (2017)
Merck & Company Agreements (2018/2017)
Sanofi Agreements (2018)

List of Charts

Segment of Vaccine Industry
Global Vaccines Market by Value (2013-2017)
Global Vaccines Market Forecast by Value (2018-2022)
Global Vaccines Market by Diseases (2017)
Global Vaccines Market Value by Product (2017)
Global Tail Products by Value (2013-2017)
Global Tail Products Forecast by Value (2018-2022)
Global New and Pipeline Products by Value (2013-2022)
Global Vaccines Market Value by Country Type (2017)
Global Vaccines Market Volume by Country Type (2017)
Global Vaccines Market by Region (2017)
The U.S. Vaccines Market by Value (2013-2017)
The U.S. Vaccines Market Forecast by Value (2018-2022)
India Vaccines Market by Volume (2017)
India Private Vaccines Market by Value (2013-2017)
India Private Vaccines Market Forecast by Value (2018-2022)
India Private Vaccines Market by Vaccine Type (2017)
China Vaccines Market by Value (2013-2017)
China Vaccines Market Forecast by Value (2018-2022)
China Vaccines Market by Type (2017)
China Type 1 Vaccines Market by Value (2013-2017)
China Type 1 Vaccines Market Forecast by Value (2018-2022)
China Type 2 Vaccines Market by Value (2013-2017)
China Type 2 Vaccines Market Forecast by Value (2018-2022)
China HPV Vaccines Sales Volume Forecast (2017-2022)
China HPV 4 Vaccines Sales Forecast by Value (2017-2022)
China HPV 9 Vaccines Sales Forecast by Value (2018-2022)
China Vaccines Market Penetration (2017)
Global GNI per Capita (2013-2017)
Global Healthcare Expenditure Per Capita (2013-2017)
HPV Vaccines Forecasted Demand (2017-2022)
Global Urban Population (2013-2017)
Global Uptake of Routine Immunization (2017)
Global Vaccines Expenditure Per Capita by Country (2017)
Global Number of New Vaccines launched (2013-2017)
Global Vaccines Market Share by Company (2017)
India Private Vaccines Market Share by Company (2017)
Merck & Company Sales by Segments (2017)
Merck & Company Sales and Net Income (2013-2017)
Merck & Company Research and Development Expenditure (2015-2017)
Pfizer Revenue by Segments (2017)
Pfizer Revenue and Net Income (2013-2017)
Pfizer Research and Development Expenditure (2015-2017)
Sanofi Sales by Segments (2017)
Sanofi Net Sales and Net Income (2013-2017)
Sanofi Research and Development Expenditure (2015-2017)
GlaxoSmithKline Turnover by Segments (2017)
GlaxoSmithKline Turnover and Profit of the Year (2013-2017)
GlaxoSmithKline Research and Development Expenditure (2015-2017)

  • Global Cancer Vaccines Industry Market Research Report
    Published: 11-Apr-2019        Price: US 2960 Onwards        Pages: 136
    The Cancer Vaccines market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Cancer Vaccines industrial chain, this report mainly elaborates the definition, types, applications and major players of Cancer Vaccines market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry developme......
  • Global Cancer Vaccine Market Research Report 2019
    Published: 27-Mar-2019        Price: US 2900 Onwards        Pages: 95
    Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system's ability to fight against infections and diseases. It is used either as stand-alone therapies or in combination with traditional cancer therapeutics such as chemotherapy and surgery. As cancer is often associated with high mortality rate and are resistant to traditional treatments like chemotherapy and radiation, this has led to the research and development of anti-cancer immunot......
  • Global BCG Vaccine Market Analysis 2013-2018 and Forecast 2019-2024
    Published: 24-Mar-2019        Price: US 2980 Onwards        Pages: 70
    Summary BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme. Besides, BCG Vaccine is also used......
  • Global BCG Vaccine Industry Market Research 2019
    Published: 22-Mar-2019        Price: US 2600 Onwards        Pages: 149
    In this report, we analyze the BCG Vaccine industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also make a predic......
  • Global Dendritic Cell Cancer Vaccine Market Research Report 2019
    Published: 15-Mar-2019        Price: US 2900 Onwards        Pages: 101
    Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. The global Dendritic Cell Cancer Vaccine market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Dendritic Cell Cancer Vaccine volume and value at global......
  • Global Cancer Vaccines Market Research Report 2019
    Published: 13-Mar-2019        Price: US 2900 Onwards        Pages: 94
    Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes. Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and vendors' patient-assistance programs also augment growth in the cancer vaccines market. Dendritic cells are cells taken from a patient's immune system and treated with chemicals before being in......
  • Global Peptide Cancer Vaccine Market Insights, Forecast to 2025
    Published: 08-Mar-2019        Price: US 3900 Onwards        Pages: 117
    Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The unde......
  • Cancer Vaccines Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 08-Mar-2019        Price: US 3000 Onwards        Pages: 141
    Cancer Vaccines Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Vaccines manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Cancer Vaccines ma......
  • Global Peptide Cancer Vaccine Market Growth 2019-2024
    Published: 20-Feb-2019        Price: US 3660 Onwards        Pages: 166
    Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The unde......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs